HomeProductsBioactive CompoundsAnti-Infective AgentsAntibacterial AgentsBesifloxacin
Chemical structure of CAS 141388-76-3

Besifloxacin

In Stock•Starting at $184 for 25 mg
CAS No.141388-76-3
MDL No.N/A
MFC19H21ClFN3O3
MW393.80
InChI KeyQFFGVLORLPOAEC-SNVBAGLBSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
25 mgTo Be Confirmed$184In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Besifloxacin is a quinoline derivative.

CAS No.141388-76-3
Product NameBesifloxacin

Associated Conditions

bacterial conjunctivitis·corneal ulcer·eye infection·cataract
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.

Antimicrobial agents and chemotherapy • Vol. 53, Issue 8 • 2009
PMID: 19506065PMC: PMC2715578DOI: 10.1128/AAC.00418-09

Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.

The Journal of antimicrobial chemotherapy • Vol. 63, Issue 3 • 2009
PMID: 19147516DOI: 10.1093/jac/dkn528

Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis.

Current medical research and opinion • Vol. 25, Issue 5 • 2009
PMID: 19323612DOI: 10.1185/03007990902837919

Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.

Clinical therapeutics • Vol. 31, Issue 3 • 2009
PMID: 19393842DOI: 10.1016/j.clinthera.2009.03.010

Documentation

Similar Products